Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03754608 · ClinicalTrials.gov registry record
Validating Imaging Biomarkers of Small Vessel Disease in Diabetic Individuals Using Advanced MRI Techniques.
A clinical trial, sponsored by Yale University.
- Completed
- Registry status
- 63
- Enrollment target
NCT03754608 is a clinical trial that has completed, run by Yale University. The registered enrollment target is 63 participants.
The verdict
NCT03754608 has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 63 participants
- Enrollment target
Study Summary
To develop a set of biomarkers for imaging of small vessel disease in diabetic individuals using advanced MRI techniques. With this the investigators want to document progression of disease both radiologically and clinically.
Interventions
- DIAGNOSTIC_TEST MRI including cf-MRI, DTI, ASL and CVR.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 63 participants |
| Start Date | 2018-11-07 |
| Est. Completion | 2020-08-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03754608
The ClinicalTrials.gov registry entry for NCT03754608 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MRI including cf-MRI, DTI, ASL and CVR. is the first listed.
NCT03754608 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03754608 about?
NCT03754608 is a clinical study titled "Validating Imaging Biomarkers of Small Vessel Disease in Diabetic Individuals Using Advanced MRI Techniques.". To develop a set of biomarkers for imaging of small vessel disease in diabetic individuals using advanced MRI techniques. With this the investigators want to document progression of disease both radiologically and clinically.
What is the current status of trial NCT03754608?
This trial is currently completed. The enrollment target is 63 participants. The study started on 2018-11-07. Estimated completion is 2020-08-31.
What interventions are being tested in trial NCT03754608?
The interventions under investigation include: MRI including cf-MRI, DTI, ASL and CVR. (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03754608?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.